Cochlear Implantation in Ménière’s Disease
Audiology and Neurotology · 2025
DOI: 10.1159/000547572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Audiology and Neurotology, 2025. Verfasst von Justin Cottrell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, NYU Langone, New York, New York, USA, justin.cottrell@nyulangone.org. Hauptthemen laut MEDLINE: Meniere Disease, Cochlear Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Cochlear implantation has demonstrated benefit for restoring hearing in patients with Ménière’s disease. We sought to examine disease and management factors that may influence postoperative speech performance and vertigo control.
Methods
A single-center retrospective chart review between 2010 and 2023 of patients with Ménière’s disease receiving a cochlear implant (CI). The primary outcome was 1-year postoperative word recognition score on Consonant-Nucleus-Consonant (CNC) testing. Postoperative vertigo control was assessed as a secondary outcome. Variables including concurrent labyrinthectomy, pre- and postoperative Ménière’s disease symptoms and treatments, duration of deafness, and hearing loss laterality were analyzed.
Results
Twenty-five patients were identified over the study period. Of those, 9 (36%) also underwent labyrinthectomy; 6 (67%) were performed simultaneously with CI and 3 (33%) received a CI following surgical ablation. There was a statistically significant (p = 0.03) higher rate of bilateral Ménière’s disease in the CI-only cohort (n = 9, 56%), compared to the cochlear implant and labyrinthectomy (CI + L) cohort (n = 1, 11%). There was also a higher rate of preoperative uncontrolled vertigo (n = 5, 56%) in the CI + L cohort compared to the CI-only cohort (n = 3, 20%), although this did not reach statistical significance (p = 0.08). The average pre- and postoperative CNC score for the CI + L cohort was 3.6 (SD 5.9) and 36.7 (SD 17.5), respectively, and 7.1 (SD 10.1) and 62.1 (SD 14.3) for the CI-only group. There was a statistically significant difference noted at most recent CNC follow-up testing (p = 0.01) between the CI + L and CI-only group.
Conclusion
Patients with Ménière’s disease meeting CI candidacy criteria may undergo CI safely and achieve speech performance benefit. A trend toward worse performance in patients who undergo concurrent labyrinthectomy with CI compared to CI alone was seen which warrants further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, NYU Langone, New York, New York, USA, justin.cottrell@nyulangone.org.
- Department of Otolaryngology - Head and Neck Surgery, NYU Langone, New York, New York, USA.
Zitieren
APA
Cottrell, J., Winchester, A., Friedmann, D., McMenomey, S., Roland, J. T., & Jethanamest, D. (2025). Cochlear Implantation in Ménière’s Disease. Audiology and Neurotology. https://doi.org/10.1159/000547572
Vancouver
Cottrell J, Winchester A, Friedmann D, McMenomey S, Roland JT, Jethanamest D. Cochlear Implantation in Ménière’s Disease. Audiology and Neurotology. 2025. doi:10.1159/000547572
BibTeX
@article{Cottrell2025,
author = {Cottrell, Justin and Winchester, Arianna and Friedmann, David and McMenomey, Sean and Roland, J Thomas and Jethanamest, Daniel},
title = {Cochlear Implantation in Ménière’s Disease},
journal = {Audiology and Neurotology},
year = {2025},
doi = {10.1159/000547572}
}
EUVIMED